Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 11—November 2011

Congenital Syphilis, Réunion Island, 2010

Juliana Ramiandrisoa, Lydéric Aubert, Emilie Boidin Lespine, Jean-Luc Alessandri, Pierre-Yves Robillard, Marc Bertsch, Anne Gallay, Véronique Goulet, and Eric D’OrtenzioComments to Author 
Author affiliations: Regional Office of French Institute for Public Health Surveillance in the Indian Ocean, Saint-Denis, Réunion Island, France (J. Ramiandrisoa, L. Aubert, E.B. Lespine, E. D’Ortenzio); Regional Hospital, Saint-Denis (J.-L. Alessandri, P.-Y. Robillard); Centre Hospitalier Gabriel Martin, Saint-Paul, Réunion Island (M. Bertsch); French Institute for Public Health Surveillance, Saint-Maurice, France (A. Gallay, V. Goulet)

Main Article


Clinical and biological characteristics of mothers and children with congenital syphilis, Réunion Island, 2010*

Year of diagnosis Mother

Age, y Time of syphilis screening Duration of treatment, d Presence andsatage of disease Positive serologic titer test results Gestation, wk Clinical signs
2008 16 >13 wk gestation 5 d BD Probable secondary syphilis at first trimester TPHA, VDRL, FTA-ABS 34 None
2008 25 Unknown 2 d AD NA TPHA, VDRL, FTA-ABS 34 None
2008 16 AD 14 d AD Primary syphilis at third trimester TPHA, VDRL, FTA-ABS 38 None
2009 26 >13 wk gestation 17 d BD NA TPHA, VDRL, FTA-ABS 31 Present
2009 18 >13 wk gestation 2 d BD NA TPHA, VDRL 32 Present
2009 22 >13 wk gestation 1 d BD NA TPHA, VDRL 32 Present
2009 37 After delivery 1 d AD NA TPHA, VDRL 38 None

*BD, before delivery; TPHA, Treponema pallidum hemagglutination assay; VDRL, Venereal Disease Research Laboratory; FTA-ABS, fluorescent treponemal antibody absorption; AD, after delivery; NA, not applicable.

Main Article

Page created: October 24, 2011
Page updated: October 24, 2011
Page reviewed: October 24, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.